PortViewPortView
Protagenic Therapeutics logo

Protagenic Therapeutics (PTIXW) Stock Analysis

NASDAQHealthcareBiotechnology

$0.02-6.25%
1-year price historyRange $0.00 – $0.17
52-week range$0.02
$0.02$0.03

What Protagenic Therapeutics does

Protagenic Therapeutics, Inc. is a biopharmaceutical company in its pre-clinical phase, dedicated to discovering and formulating treatments for neuropsychiatric and mood disorders that are related to stress. Its flagship compound, PT00114, is a laboratory-produced variant of teneurin carboxy-terminal associated peptide, a naturally occurring brain signaling peptide recognized for its capacity to moderate excessive stress reactions. The firm was established in 2016 and maintains its principal office in New York, New York.

Key metrics

Market cap
$27,160
P/E (TTM)
0.00
EPS (TTM)
$0.00
Beta
0.47
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$0.03
200-day avg
$0.04
52-week high
$0.03
52-week low
$0.02
CEO
Garo H. Armen

ETFs linked to PTIXW

Broad-market and Healthcare sector ETFs an investor holding Protagenic Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how PTIXW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PTIXW in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Protagenic Therapeutics?
Protagenic Therapeutics trades under the ticker PTIXW on NASDAQ.
Which exchange is PTIXW listed on?
PTIXW is listed on NASDAQ.
What sector does Protagenic Therapeutics operate in?
Protagenic Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze PTIXW in a portfolio?
PortView shows PTIXW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.